Zydus and Bioeq Join Forces to Launch NUFYMCO® in the U.S. Market Zydus Lifesciences partners with Bioeq AG to commercialize NUFYMCO®, a groundbreaking biosimilar of Lucentis®, following FDA approval.

Zydus and Bioeq Join Forces to Launch NUFYMCO® in the U.S. Market #India #Ahmedabad #NUFYMCO #Bioeq #Zydus